
Critical Vulnerability in Thermo Fisher Genetic Analyzers: CVE-2026-17583
In August 2026, Thermo Fisher Scientific disclosed a critical vulnerability (CVE-2026-17583) in their Applied Biosystems Genetic Analyzers. The flaw allowed unauthorized modification of .fsa and .hid output files, potentially leading to inaccurate DNA test results. Affected products included various versions of the 3500/3500xL, 3730/3730xL, SeqStudio, SeqStudio Flex, GeneMapper ID-X, 3130 Series, ABI PRISM 3100/3100-Avant, and ABI PRISM 310 Data Collection Software. Thermo Fisher released security updates to address the issue, implementing digital signatures to verify data file integrity. This incident underscores the critical importance of data integrity in medical devices, especially those used in genetic analysis. The vulnerability highlights the need for robust security measures to prevent unauthorized data manipulation, which can have significant implications for patient care and research outcomes.
Kill Chain



